chr2-200891952-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000359683.8(NIF3L1):c.-56-17A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000674 in 1,604,236 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 1 hom. )
Consequence
NIF3L1
ENST00000359683.8 splice_polypyrimidine_tract, intron
ENST00000359683.8 splice_polypyrimidine_tract, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00700
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 2-200891952-A-G is Benign according to our data. Variant chr2-200891952-A-G is described in ClinVar as [Benign]. Clinvar id is 720553.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIF3L1 | NM_001369441.2 | c.9A>G | p.Ser3= | synonymous_variant | 2/7 | ENST00000409020.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIF3L1 | ENST00000409020.6 | c.9A>G | p.Ser3= | synonymous_variant | 2/7 | 5 | NM_001369441.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 535AN: 152140Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
535
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000862 AC: 205AN: 237744Hom.: 1 AF XY: 0.000612 AC XY: 79AN XY: 129052
GnomAD3 exomes
AF:
AC:
205
AN:
237744
Hom.:
AF XY:
AC XY:
79
AN XY:
129052
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000375 AC: 545AN: 1451978Hom.: 1 Cov.: 30 AF XY: 0.000324 AC XY: 234AN XY: 721398
GnomAD4 exome
AF:
AC:
545
AN:
1451978
Hom.:
Cov.:
30
AF XY:
AC XY:
234
AN XY:
721398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00352 AC: 536AN: 152258Hom.: 4 Cov.: 32 AF XY: 0.00342 AC XY: 255AN XY: 74458
GnomAD4 genome
AF:
AC:
536
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
255
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at